Showing 1,821 - 1,840 results of 5,782 for search 'significantly ((observed decrease) OR (((teer decrease) OR (greater decrease))))', query time: 0.33s Refine Results
  1. 1821

    CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

    Published 2024
    “…The interventions had statistically significant effects only on decreasing the prevalence of overweight and obesity. …”
  2. 1822
  3. 1823

    a, Anti-correlation of gene expression between <i>dmdR1</i> and its predicted regulon. Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875.... by Hannah E. Augustijn (10773096)

    Published 2025
    “…Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875. …”
  4. 1824

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  5. 1825

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  6. 1826

    Antibody description. by Qi He (384033)

    Published 2025
    “…Furthermore, HRW decreased Cytc, Bax, Caspase-3, and Caspase-8 levels, and increasing the expression of Bcl-2. …”
  7. 1827

    Raw data of this article. by Qi He (384033)

    Published 2025
    “…Furthermore, HRW decreased Cytc, Bax, Caspase-3, and Caspase-8 levels, and increasing the expression of Bcl-2. …”
  8. 1828
  9. 1829

    Antibiotic Resistome Changes Associated with Different Types of Corrosion Inhibitors When Chlorine is Used as a Disinfectant by Lee K. Kimbell (21520910)

    Published 2025
    “…In general, most of the ARGs were associated with chromosomes, but a significant increase in the number of ARGs colocated with plasmid and integron sequences was observed. …”
  10. 1830

    Characteristics of the included studies. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  11. 1831

    Summary of results. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  12. 1832

    Bias risk assessments for each RCT study. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  13. 1833

    The flow chart of studies selecting. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  14. 1834

    Funnel plots for intraoperative blood loss. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  15. 1835

    Bias risk assessments for each RCS study. by Xin Liu (43569)

    Published 2025
    “…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”
  16. 1836

    Different metabolite quantities between groups. by Ye Cheng (513097)

    Published 2025
    “…Colonic epithelial tissue disruption, mucus cells reduction, and a decreased expression of intestinal tight junction proteins were observed in the CO, SC, and SO groups. …”
  17. 1837

    Characteristics of the participants. by Kazuhiro Suzuki (160528)

    Published 2025
    “…Among the 109 participants (12 with schizophrenia, 55 with mood disorders, 34 with anxiety disorders, and 8 with other conditions), a significant reduction in psychological distress was observed after the guideline relaxation (Cohen’s d = 0.344, p < 0.01). …”
  18. 1838
  19. 1839
  20. 1840